Israel has been devoted to cannabis research on a large scale, and for a longer amount of time, more than any other country in the world. Now, one of their top cannabis companies is coming to America.
“Tikun Olam is the gold standard for pharmaceutical grade medical cannabis production in both Israel and Canada. The US cannabis market is becoming more sophisticated, looking beyond high-THC content to demand medically-proven, quality products for therapeutic cannabis use as part of a healthy lifestyle,”
said Bernard Sucher, CEO of T.O. Global LLC.
“We are confident that entering the medical and adult-use U.S. market with a genuine approach to health and wellness, will position Tikun for a successful expansion where regulated markets exist.”
Tikun Olam, which will be named Tikun in the United States, will license its intellectual property, methodology, and years of experience to CW Nevada LLC, and will distribute cannabis products to Nevada dispensaries.
Cannabis research in Israel dates back to the mid 1960’s. While researchers in the United States have been forced to work inconspicuously due to federal regulation, Israel’s Ministry of Health has welcomed cannabis research, and is actively funding and facilitating research efforts. Tikum Olam is the largest medical marijuana producer in Israel, and distributes its products in Canada as well. Their clinical data gathered during years of research has helped develop medical marijuana products that achieve results, validated by feedback from patients. In an environment where research can be conducted openly, Tikun Olam opened a clinic where patients can learn about delivery methods and strains designed to treat their specific condition.
The United States has made progress legalizing medical marijuana, and recreational marijuana achieved victories in November with California, Massachusetts, Nevada, and Maine all legalizing. This means one in five Americans now have access to legal marijuana, which makes a collaboration with a leading Israeli cannabis company a significant addition to the American cannabis market.
“We’ve been watching the Israeli market and the incredible innovation that is coming from there, especially with the government supporting cannabis as a medical plant,”
said Jeffrey M. Zucker, President of Green Lion Partners, a strategy firm in the cannabis industry.
“The excitement surrounding new regulations that will allow cannabis export from Israel was palpable,” Zucker stated, after attending the annual Cannatech conference in March.
Nevada cannabis customers can expect to see cannabis flowers, vape cartridges, tinctures, topical products and edibles licensed by Tikun. Their strains range from strong sativas to high-CBD strains with no psychoactive effects, catering to recreational consumers and medical patients alike.